Morningside Venture Investments Limited 13D and 13G filings for Kezar Life Sciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-16 6:33 pm Sale | 2024-12-03 | 13D | Kezar Life Sciences, Inc. KZR | Morningside Venture Investments Limited | 616,502 8.450% | -8,953 (-1.43%) | Filing |
| 2023-08-17 5:14 pm Unchanged | 2023-08-15 | 13D | Kezar Life Sciences, Inc. KZR | Morningside Venture Investments Limited | 625,455 8.600% | 0 (Unchanged) | Filing |
| 2021-02-16 4:15 pm Unchanged | 2020-12-31 | 13D | Kezar Life Sciences, Inc. KZR | Morningside Venture Investments Limited | 625,455 13.500% | 0 (Unchanged) | Filing |
| 2020-06-16 4:10 pm Purchase | 2020-06-11 | 13D | Kezar Life Sciences, Inc. KZR | Morningside Venture Investments Limited | 625,455 13.700% | 14,549 (+2.38%) | Filing |